Browsing Tag
Sasanlimab
1 post
Pfizer breakthrough: New immunotherapy combo slashes bladder cancer recurrence risk by 32%
Discover how Pfizer’s new sasanlimab combination therapy is redefining treatment for high-risk bladder cancer after 30 years — read the breakthrough results now!